There were 1,661 press releases posted in the last 24 hours and 359,338 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Idera Pharmaceuticals to Present Phase 1/2 IMO-8400 Clinical Data in Waldenstrom’s Macroglobulinemia at the 2015 American Society of Hematology Annual Meeting

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image